Jul 28, 2017 12:00 PM EDT
AMD, after introducing the Ryzen 7 and Ryzen 5, has now released the entry level Ryzen 3 series of desktop processors. The company has launched the two model series namely AMD Ryzen 3 1200 and the 1300X.
AMD Ryzen 3 is equipped with the real quad-core free performance, as can be used for gaming and computing. The newly launched processors contain the large and growing AM4 motherboard ecosystem.
The $129 Ryzen 3 1300X has four cores and four threads with a base clock of 3.5GHz and boost clock of 3.7GHz. It can go up to 3.9GHz with XFR provided the stock Wraith Stealth cooler and get an aftermarket one like the new $59 Wreath Max with RGB lighting, as reported by GSM Arena.
Another launched, $109 Ryzen 3 1200 also boasts four cores and four threads with a base clock of 3.1GHz and boost clock of 3.4GHz. Both newly launched processors have 65W TDP and are compatible with motherboards using X370, B350, and A320 chipsets.
The Ryzen 3 is said t be competing against the Intel Core i3 processors that are all dual core processors with four threads, so AMD's push on the "true quad-core" branding. Also, both AMD Ryzen 3 models are overclockable and all needed is a standard B350 motherboard, while only one model in the entire i3 range is overclockable and requires a more expensive Z270 board.
AMD said that they released the highly familiar 7th Generation Series desktop processor earlier. They launched the X4 CPU for the socket AM4. It is the entry-level processor that will give the solutions for the advanced platform, as noted by Phone Mantra.
The AMD has also launched 7th Gen A-series, Athlon X4, and Ryzen 3 processors are more compatible with mature socket AM4 socket. It is the entry-level CPUs, and Ryzen 7 1800X sports the high-end 8-core/16-thread.
2. Aug 21, 2018
Study: Length of opioid prescription spell highest risk for misuse after surgery
3. Aug 06, 2018
NASA Introduces First Batch Of Commercial Astronaut Crew
4. Jul 31, 2018
Pair of colliding stars spill radioactive molecules into space
2. Jul 26, 2018
New system can identify drugs to target 'undruggable' enzymes critical in many diseases
3. Jul 26, 2018
Health benefits of moderate drinking may be overstated, study finds